Document is current

Article History

Received: 13 November 2023

Accepted: 26 December 2023

First Online: 20 February 2024

Declarations

:

: Swespine uses the opt-out method, meaning that patient consent is not needed to be part of the quality registry, but answering the questionnaires is voluntary. The Regional and National Ethical Review Boards authorized the study and the use of the data collection (Dnr: 2016/1708–31/4, 2020–00193, 2021–04773, 2021–00759, 2022–00187).

: The authors declare no competing interests.

: The funding sources had no role in the study design, analysis, or interpretation of the data; in the manuscript writing; or in the decision to submit the paper for publication. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.